Your browser doesn't support javascript.
loading
Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma.
Soon, Gwyneth S T; Callea, Francesco; Burt, Alastair D; Cook, Sam; Terracciano, Luigi; Ercan, Caner; Dienes, Hans-Peter; Goodman, Zachary D; Roberts, Eve A; Clouston, Andrew D; Gouw, Annette S H; Kleiner, David E; Park, Young Nyun; Chung, Taek; Schirmacher, Peter; Tiniakos, Dina; Dimopoulou, Konstantina; Weber, Achim; Endhardt, Katharina; Torbenson, Michael.
Afiliación
  • Soon GST; Department of Pathology, National University Hospital, Singapore.
  • Callea F; Ospedale Pediatrico Bambino Gesu, 00165 Rome, Italy.
  • Burt AD; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Cook S; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  • Terracciano L; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy.
  • Ercan C; Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland.
  • Dienes HP; Institute of Pathology, Meduniwien, Medical University of Vienna, 1090 Wien, Austria.
  • Goodman ZD; Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA 22042, USA.
  • Roberts EA; Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario M5G1X8, Canada.
  • Clouston AD; Centre for Liver Disease Research, School of Medicine (Southern), University of Queensland, Princess Alexandra Hospital, Ipswich Rd Woolloongabba 4109, Australia.
  • Gouw ASH; Department of Pathology and Medical Biology, University Medical Center Groningen, 9700 RB Groningen, the Netherlands.
  • Kleiner DE; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Park YN; Department of Pathology, Yonsei University College of Medicine, Seoul Korea.
  • Chung T; Department of Pathology, Yonsei University College of Medicine, Seoul Korea. Electronic address: jtaek0517@yuhs.ac.
  • Schirmacher P; Institute of Pathology, University Hospital, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.
  • Tiniakos D; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom; Department of Pathology, Aretaieion Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
  • Dimopoulou K; Department of Pathology, Aretaieion Hospital, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
  • Weber A; Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Endhardt K; Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Torbenson M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: Torbenson.Michael@mayo.edu.
Hum Pathol ; 149: 55-65, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38876199
ABSTRACT
Histological subtyping of hepatocellular carcinoma (HCC) is challenging in the presence of histological heterogeneity, where distinctly different morphological patterns are present within the same tumor. Current approaches rely on percent cut-offs. We hypothesized that morphologic intratumor heterogeneity is a non-random biological feature and that incorporating recurrent patterns would improve histological subtyping of HCC. Resected HCC were studied and the overall frequency of morphologic intratumor heterogeneity was 45% in 242 specimens. Steatohepatitic HCC (SH-HCC) had the highest frequency of morphologic intratumor heterogeneity (91%); this was confirmed in additional cohorts of SH-HCC from different medical centers (overall frequency of 78% in SH-HCC). Morphologic intratumor heterogeneity in SH-HCC showed distinct and recurrent patterns that could be classified as early, intermediate, and advanced. Incorporating these patterns into the definition of SH-HCC allowed successful resolution of several persistent challenges the problem of the best cut-off for subtyping SH-HCC, the problem of the relationship between SH-HCC and scirrhous HCC, and the classification for HCC with abundant microvesicular steatosis. This approach also clarified the relationship between SH-HCC and CTNNB1 mutations, showing that CTNNB1 mutations occur late in a subset of SH-HCC. In summary, there is a high frequency of morphologic intratumor heterogeneity in HCC. Incorporating this finding into histological subtyping resolved several persistent problems with the SH-HCC subtype.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Beta Catenina / Hígado Graso / Neoplasias Hepáticas / Mutación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Beta Catenina / Hígado Graso / Neoplasias Hepáticas / Mutación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Singapur